Substantiation of Using Pimecrolimus 1% Cream in Proactive Therapy of Children with Atopic Dermatitis-Reference-Cited by-同舟云学术

Substantiation of Using Pimecrolimus 1% Cream in Proactive Therapy of Children with Atopic Dermatitis

Published:2021-11-07 Issue:5 Volume:20 Page:376-382
ISSN:1682-5535
Container-title:Current Pediatrics
language:
Short-container-title:Vopr. sovr. pediatr.

Author:

Murashkin Nikolay N.¹^ORCID,Ivanov Roman A.²^ORCID,Ambarchian Eduard T.³^ORCID,Epishev Roman V.⁴^ORCID,Materikin Alexander I.⁴^ORCID,Opryatin Leonid A.⁴^ORCID,Savelova Alena A.⁴^ORCID

Affiliation:

1. National Medical Research Center of Children's Health; Sechenov First Moscow State Medical University (Sechenov University); Central State Medical Academy

2. National Medical Research Center of Children's Health; Central State Medical Academy

3. Research Institute of Pediatrics and Children's Health in “Central Clinical Hospital of the Russian Academy of Sciences”

4. National Medical Research Center of Children's Health

Abstract

Atopic dermatitis (AtD) is multifactorial inflammatory skin disease with high prevalence in pediatric population. It is crucial to implement long-term maintenance therapy to prevent AtD exacerbations according to current clinical guidelines and expert reports. The article summarizes the results of the major studies on using pimecrolimus 1% cream. Its efficacy and safety in long-term proactive therapy of children with AtD are presented.

Publisher

Paediatrician Publishers LLC

Subject

Pediatrics, Perinatology and Child Health

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proactive therapy for atopic dermatitis;Meditsinskiy sovet = Medical Council;2024-08-07

2. Pimecrolimus in the clinical practice of a dermatologist;Meditsinskiy sovet = Medical Council;2022-07-13